The Clinical Dermatology deals with diagnosis and treatment for all skin, hair and nail diseases and disorders - whether primary or related to an underlying systemic illness.
The dermatology drugs market size is expected to reach $40 billion by 2022, significantly growing at a CAGR of around 5% during the forecast period. The growth in the Dermatology drugs market is due to increase in the number of indications treated by topical drugs coupled with increase in acne and rosacea patients will drive the market for dermatology drugs. Read more at https://bit.ly/2BnUmRJ